Delivery Timing in Morbidly Adherent Placentas: a Randomized, Controlled Trial

The University of Texas Health Science Center, Houston

Overview

This is a randomized controlled trial to investigate the optimal timing of delivery in clinically stable women with a suspected morbidly adherent placenta.

This is a randomized controlled trial to investigate the optimal timing of delivery in clinically stable women with a suspected morbidly adherent placenta dispositioned for a scheduled delivery. The primary outcome will be assessed by comparing the composite neonatal morbidity and composite maternal morbidity between the two groups (delivery at 34 versus 36 weeks gestational age).

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

OTHER

Masking

NONE

Conditions

Morbidly Adherent Placenta Placenta Accreta

Interventions

Scheduled timing of deliveryOTHER

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 50 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Women with monographically morbidly adherent placenta with or without a placenta previa. * Scheduled delivery via cesarean hysterectomy Exclusion Criteria: * Delivery planned prior to 36 weeks (e.g. non-reassuring fetal status, preterm labor, severe preeclampsia, other medical/fetal indication for delivery as determined by the managing physician).

Outcomes

Primary Outcomes

Composite neonatal morbidity

Time frame: Within 72 hours of newborn discharge

Maternal neonatal morbidity

Time frame: Within 72 hours of patient discharge

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.